Bomyntra 120 MG per 1.7 ML Prefilled Syringe

RxCUI: 2717555
RxNorm name: Bomyntra 120 MG per 1.7 ML Prefilled Syringe
Display name: Bomyntra 120 MG per 1.7 ML Prefilled Syringe
Full name: Bomyntra 120 MG per 1.7 ML Prefilled Syringe
Term type: SY
Status: DailyMed mapping
Updated: 2026-06-04 23:38:56

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLA	Proprietary name	Proper name	License type	Status	Latest source
761398	Conexxence	denosumab-bnht	351(k) Interchangeable	Rx	2026-07-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
BOMYNTRA	DENOSUMAB	Fresenius Kabi USA, LLC	49d25732-e05d-47e4-98cb-67df04796d4b	2025-03-31	Warnings, Adverse reactions	Exact identifier rxcui: 2717555

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
49d25732-e05d-47e4-98cb-67df04796d4b	Bomyntra 120 MG in 1.7 ML Prefilled Syringe [PSN] · 1.7 ML denosumab-bnht 70 MG/ML Prefilled Syringe [Bomyntra] [SBD] · Bomyntra 120 MG per 1.7 ML Prefilled Syringe [SY] · Bomyntra 70 MG/ML per 1.7 ML Prefilled Syringe [SY]	4	3	These highlights do not include all the information needed to use BOMYNTRA safely and effectively. See full prescribing information for BOMYNTRA. BOMYNTRA (denosumab-bnht) injection, for subcutaneous use Initial U.S. Approval: 2025 BOMYNTRA (denosumab-bnht) is biosimilar Biosimilar means that the biological product is approved based on data demonstrating that it is highly similar to an FDA-approved biological product, known as a reference product, and that there are no clinically meaningful differences betw	20250331